Cassava Sciences | PTIE - Capitalização De Mercado





Capitalização De Mercado Alterar Data
Abbott USD 178.41B 39.46B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Cara Therapeutics USD 366M 338M 2025-09
Cassava Sciences USD 96M 45M 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Geron USD 946M 9M 2026-05
J&J USD 579.15B 78.91B 2026-03
Merck USD 297.1B 35.84B 2026-03
Novartis USD 232.75B 75B 2026-05
Novavax USD 1.09B 316M 2025-12
Pfizer USD 147.4B 6.42B 2026-05
Roche Holding CHF 266.34B 55.46B 2025-12